“…These molecules bind to surface receptors belonging to the type I IFNAR complex, which in turn activate several intracellular signaling pathways that promote the activation of anti-viral responses [83,84]. Such cellular responses are characterized by the expression of interferon-stimulated genes (ISGs) [52,55,72,77,78,81,84,85] that trigger effector functions which include the activation of ribonuclease L for RNA degradation [86], proliferation and activation of NK cells [87]. In the lungs, production of type I IFNs derives mainly from plasmacytoid dendritic cells (pDCs), epithelial cells and macrophages [88,89].…”